世界各国のリアルタイムなデータ・インテリジェンスで皆様をお手伝い

3Dバイオプリンティング市場：コンポーネント別（3Dバイオプリンター（マイクロ押し出し、インクジェット、レーザー、磁気）、バイオインク（天然、合成、ハイブリッド））、材料別（ハイドロゲル、生体細胞）、用途別（研究、臨床）、エンドユーザー別（バイオ医薬品、アカデミア）、地域別展望 2030年までの世界予測


3D Bioprinting Market based on by Component (3D Bioprinters (Microextrusion, Inkjet, Laser, Magnetic), Bioink (Natural, Synthetic, Hybrid)), Material (Hydrogel, Living Cells), Application (Research, Clinical), End User (Biopharma, Academia) ,Regional Outlook Global Forecast up to 2030

世界中の政府がプロジェクトを立ち上げ、教育機関、研究センター、研究技術組織を後援して、3Dプリント技術の開発をさらに調査し、刺激しています。米国、英国、カナダはいずれも、大学レベルの3Dプリンティング... もっと見る

　

　

出版社 出版年月 電子版価格 ページ数 言語
IHR Insights
アイエイチアールインサイト 		2024年1月10日 US$4,500
シングルユーザライセンス
ライセンス・価格情報
注文方法はこちら 		128 英語

　

サマリー

世界中の政府がプロジェクトを立ち上げ、教育機関、研究センター、研究技術組織を後援して、3Dプリント技術の開発をさらに調査し、刺激しています。米国、英国、カナダはいずれも、大学レベルの3Dプリンティング研究の育成、技術革新の加速、新興企業の設立を目的とした政府プログラムを立ち上げています。3Dプリンティングの斬新な用途の出現は、世界中の企業や政府の関心を刺激している。例えば、英国の「積層造形国家戦略2023-2030」は、2030年までに年間総付加価値額（GVA）35億ユーロの達成と、産業全体で6万人の雇用を目指している。この計画は、特定のテーマを担当するワークグループによって作成された包括的な提案の集合体である。

ページTOPに戻る


目次

1. Executive Summary
2. Industry Outlook
2.1. Industry Overview
2.2. Industry Trends
3. Market Snapshot
3.1. Market Definition
3.2. Market Outlook
3.2.1. Porter Five Forces
3.3. Related Markets
4. Market characteristics
4.1. Market Overview
4.2. Market Segmentation
4.3. Market Dynamics
4.3.1. Drivers
4.3.2. Restraints
4.3.3. Opportunities
4.4. DRO - Impact Analysis
5. Component: Market Size & Analysis
5.1. Overview
5.2. 3D Bioprinters
5.3. Bioinks
6. Application: Market Size & Analysis
6.1. Overview
6.2. Research applications
6.3. Clinical applications
7. End Users: Market Size & Analysis
7.1. Overview
7.2. Research Organizations and Academic Institutes,
7.3. Biopharmaceutical companies
7.4. Hospitals
8. Geography: Market Size & Analysis
8.1. Overview
8.2. North America (U.S., Mexico, Canada)
8.3. Europe (France, Germany, UK, Italy, Netherlands, Spain, Russia, Rest of Europe)
8.4. Asia Pacific (Japan, China, India, Australia, South East Asia, Rest of APAC)
8.5. Latin America (Brazil, Argentina)
8.6. Middle East & Africa (Saudi Arabia, UAE, South Africa, Rest of Middle East and Africa)
9. Competitive Landscape
9.1. Competitor Comparison Analysis
9.2. Market Developments
9.2.1. Mergers and Acquisitions, Legal, Awards, Partnerships
9.2.2. Product Launches and execution
10. Vendor Profiles
10.1. ENVISIONTEC, INC.
10.1.1. Overview
10.1.2. Financial Overview
10.1.3. Product Offerings
10.1.4. Developments
10.1.5. Business Strategy
10.2. ORGANOVO HOLDINGS, INC.
10.2.1. Overview
10.2.2. Financial Overview
10.2.3. Product Offerings
10.2.4. Developments
10.2.5. Business Strategy
10.3. INVENTIA LIFE SCIENCE PTY LTD
10.3.1. Overview
10.3.2. Financial Overview
10.3.3. Product Offerings
10.3.4. Developments
10.3.5. Business Strategy
10.4. POIETIS
10.4.1. Overview
10.4.2. Financial Overview
10.4.3. Product Offerings
10.4.4. Developments
10.4.5. Business Strategy
10.5. VIVAX BIO, LLC
10.5.1. Overview
10.5.2. Financial Overview
10.5.3. Product Offerings
10.5.4. Developments
10.5.5. Business Strategy
10.6. ALLEVI
10.6.1. Overview
10.6.2. Financial Overview
10.6.3. Product Offerings
10.6.4. Developments
10.6.5. Business Strategy
10.7. CYFUSE BIOMEDICAL K.K.
10.7.1. Overview
10.7.2. Financial Overview
10.7.3. Product Offerings
10.7.4. Developments
10.7.5. Business Strategy
10.8. 3D BIOPRINTING SOLUTIONS
10.8.1. Overview
10.8.2. Financial Overview
10.8.3. Product Offerings
10.8.4. Developments
10.8.5. Business Strategy
10.9. CELLINK GLOBAL
10.9.1. Overview
10.9.2. Financial Overview
10.9.3. Product Offerings
10.9.4. Developments
10.9.5. Business Strategy
10.10. REGEMAT 3D S.L.
10.10.1. Overview
10.10.2. Financial Overview
10.10.3. Product Offerings
10.10.4. Developments
10.10.5. Business Strategy

11. Analyst Opinion
12. Annexure

ページTOPに戻る



図表リスト

TABLE 1. 3D BIOPRINTING MARKET VALUE, BY COMPONENT, 2021-2030 (USD BILLION)
TABLE 2. 3D BIOPRINTING MARKET VALUE FOR 3D BIOPRINTERS, BY GEOGRAPHY , 2021-2030 (USD BILLION)
TABLE 3. 3D BIOPRINTING MARKET VALUE FOR BIOINKS, BY GEOGRAPHY, 2021-2030 (USD BILLION)
TABLE 4. 3D BIOPRINTING MARKET VALUE, BY APPLICATION, 2021-2030 (USD BILLION)
TABLE 5. 3D BIOPRINTING MARKET VALUE FOR RESEARCH APPLICATIONS, 2021-2030 (USD BILLION)
TABLE 6. 3D BIOPRINTING MARKET VALUE FOR CLINICAL APPLICATIONS, BY GEOGRAPHY, 2021-2030 (USD BILLION)
TABLE 7. 3D BIOPRINTING MARKET VALUE, BY END USERS, 2021-2030 (USD BILLION)
TABLE 8. 3D BIOPRINTING MARKET VALUE FOR RESEARCH ORGANIZATIONS AND ACADEMIC INSTITUTES, BY GEOGRAPHY, 2021-2030 (USD BILLION)
TABLE 9. 3D BIOPRINTING MARKET VALUE FOR BIOPHARMACEUTICAL COMPANIES, BY GEOGRAPHY, 2021-2030 (USD BILLION)
TABLE 10. 3D BIOPRINTING MARKET VALUE FOR HOSPITALS, BY GEOGRAPHY, 2021-2030 (USD BILLION)
TABLE 11. NORTH AMERICA 3D BIOPRINTING MARKET VALUE, BY COUNTRY, 2021-2030 (USD BILLION)
TABLE 12. NORTH AMERICA 3D BIOPRINTING MARKET VALUE, BY COMPONENT, 2021-2030 (USD BILLION)
TABLE 13. NORTH AMERICA 3D BIOPRINTING MARKET VALUE, BY APPLICATION, 2021-2030 (USD BILLION)
TABLE 14. NORTH AMERICA 3D BIOPRINTING MARKET VALUE, BY END USERS, 2021-2030 (USD BILLION)
TABLE 15. U.S 3D BIOPRINTING MARKET VALUE, BY COMPONENT, 2021-2030 (USD BILLION)
TABLE 16. U.S 3D BIOPRINTING MARKET VALUE, BY APPLICATION, 2021-2030 (USD BILLION)
TABLE 17. U.S 3D BIOPRINTING MARKET VALUE, BY END USERS, 2021-2030 (USD BILLION)
TABLE 18. CANADA 3D BIOPRINTING MARKET VALUE, BY COMPONENT, 2021-2030 (USD BILLION)
TABLE 19. CANADA 3D BIOPRINTING MARKET VALUE, BY APPLICATION, 2021-2030 (USD BILLION)
TABLE 20. CANADA 3D BIOPRINTING MARKET VALUE, BY END USERS, 2021-2030 (USD BILLION)
TABLE 21. MEXICO 3D BIOPRINTING MARKET VALUE, BY COMPONENT, 2021-2030 (USD BILLION)
TABLE 22. MEXICO 3D BIOPRINTING MARKET VALUE, BY APPLICATION, 2021-2030 (USD BILLION)
TABLE 23. MEXICO 3D BIOPRINTING MARKET VALUE, BY END USERS, 2021-2030 (USD BILLION)
TABLE 24. EUROPE 3D BIOPRINTING MARKET VALUE, BY COUNTRY, 2021-2030 (USD BILLION)
TABLE 25. EUROPE 3D BIOPRINTING MARKET VALUE, BY COMPONENT, 2021-2030 (USD BILLION)
TABLE 26. EUROPE 3D BIOPRINTING MARKET VALUE, BY APPLICATION, 2021-2030 (USD BILLION)
TABLE 27. EUROPE 3D BIOPRINTING MARKET VALUE, BY END USERS, 2021-2030 (USD BILLION)
TABLE 28. GERMANY 3D BIOPRINTING MARKET VALUE, BY COMPONENT, 2021-2030 (USD BILLION)
TABLE 29. GERMANY 3D BIOPRINTING MARKET VALUE, BY APPLICATION, 2021-2030 (USD BILLION)
TABLE 30. GERMANY 3D BIOPRINTING MARKET VALUE, BY END USERS, 2021-2030 (USD BILLION)
TABLE 31. U.K 3D BIOPRINTING MARKET VALUE, BY COMPONENT, 2021-2030 (USD BILLION)
TABLE 32. U.K 3D BIOPRINTING MARKET VALUE, BY APPLICATION, 2021-2030 (USD BILLION)
TABLE 33. U.K 3D BIOPRINTING MARKET VALUE, BY END USERS, 2021-2030 (USD BILLION)
TABLE 34. FRANCE 3D BIOPRINTING MARKET VALUE, BY COMPONENT, 2021-2030 (USD BILLION)
TABLE 35. FRANCE 3D BIOPRINTING MARKET VALUE, BY APPLICATION, 2021-2030 (USD BILLION)
TABLE 36. FRANCE 3D BIOPRINTING MARKET VALUE, BY END USERS, 2021-2030 (USD BILLION)
TABLE 37. ITALY 3D BIOPRINTING MARKET VALUE, BY COMPONENT, 2021-2030 (USD BILLION)
TABLE 38. ITALY 3D BIOPRINTING MARKET VALUE, BY APPLICATION, 2021-2030 (USD BILLION)
TABLE 39. ITALY 3D BIOPRINTING MARKET VALUE, BY END USERS, 2021-2030 (USD BILLION)
TABLE 40. SPAIN 3D BIOPRINTING MARKET VALUE, BY COMPONENT, 2021-2030 (USD BILLION)
TABLE 41. SPAIN 3D BIOPRINTING MARKET VALUE, BY APPLICATION, 2021-2030 (USD BILLION)
TABLE 42. SPAIN 3D BIOPRINTING MARKET VALUE, BY END USERS, 2021-2030 (USD BILLION)
TABLE 43. ROE 3D BIOPRINTING MARKET VALUE, BY COMPONENT, 2021-2030 (USD BILLION)
TABLE 44. ROE 3D BIOPRINTING MARKET VALUE, BY APPLICATION, 2021-2030 (USD BILLION)
TABLE 45. ROE 3D BIOPRINTING MARKET VALUE, BY END USERS, 2021-2030 (USD BILLION)
TABLE 46. ASIA PACIFIC 3D BIOPRINTING MARKET VALUE, BY COUNTRY, 2021-2030 (USD BILLION)
TABLE 47. ASIA PACIFIC 3D BIOPRINTING MARKET VALUE, BY COMPONENT, 2021-2030 (USD BILLION)
TABLE 48. ASIA PACIFIC 3D BIOPRINTING MARKET VALUE, BY APPLICATION, 2021-2030 (USD BILLION)
TABLE 49. ASIA PACIFIC 3D BIOPRINTING MARKET VALUE, BY END USERS, 2021-2030 (USD BILLION)
TABLE 50. CHINA 3D BIOPRINTING MARKET VALUE, BY COMPONENT, 2021-2030 (USD BILLION)
TABLE 51. CHINA 3D BIOPRINTING MARKET VALUE, BY APPLICATION, 2021-2030 (USD BILLION)
TABLE 52. CHINA 3D BIOPRINTING MARKET VALUE, BY END USERS, 2021-2030 (USD BILLION)
TABLE 53. INDIA 3D BIOPRINTING MARKET VALUE, BY COMPONENT, 2021-2030 (USD BILLION)
TABLE 54. INDIA 3D BIOPRINTING MARKET VALUE, BY APPLICATION, 2021-2030 (USD BILLION)
TABLE 55. INDIA 3D BIOPRINTING MARKET VALUE, BY END USERS, 2021-2030 (USD BILLION)
TABLE 56. JAPAN 3D BIOPRINTING MARKET VALUE, BY COMPONENT, 2021-2030 (USD BILLION)
TABLE 57. JAPAN 3D BIOPRINTING MARKET VALUE, BY APPLICATION, 2021-2030 (USD BILLION)
TABLE 58. JAPAN 3D BIOPRINTING MARKET VALUE, BY END USERS, 2021-2030 (USD BILLION)
TABLE 59. REST OF APAC 3D BIOPRINTING MARKET VALUE, BY COMPONENT, 2021-2030 (USD BILLION)
TABLE 60. REST OF APAC 3D BIOPRINTING MARKET VALUE, BY APPLICATION, 2021-2030 (USD BILLION)
TABLE 61. REST OF APAC 3D BIOPRINTING MARKET VALUE, BY END USERS, 2021-2030 (USD BILLION)
TABLE 62. LATIN AMERICA 3D BIOPRINTING MARKET VALUE, BY COMPONENT, 2021-2030 (USD BILLION)
TABLE 63. LATIN AMERICA 3D BIOPRINTING MARKET VALUE, BY APPLICATION, 2021-2030 (USD BILLION)
TABLE 64. LATIN AMERICA 3D BIOPRINTING MARKET VALUE, BY END USERS, 2021-2030 (USD BILLION)
TABLE 65. BRAZIL 3D BIOPRINTING MARKET VALUE, BY COMPONENT, 2021-2030 (USD BILLION)
TABLE 66. BRAZIL 3D BIOPRINTING MARKET VALUE, BY APPLICATION, 2021-2030 (USD BILLION)
TABLE 67. BRAZIL 3D BIOPRINTING MARKET VALUE, BY END USERS, 2021-2030 (USD BILLION)
TABLE 68. ARGENTINA 3D BIOPRINTING MARKET VALUE, BY COMPONENT, 2021-2030 (USD BILLION)
TABLE 69. ARGENTINA 3D BIOPRINTING MARKET VALUE, BY APPLICATION, 2021-2030 (USD BILLION)
TABLE 70. ARGENTINA 3D BIOPRINTING MARKET VALUE, BY END USERS, 2021-2030 (USD BILLION)
TABLE 71. MIDDLE EAST AND AFRICA 3D BIOPRINTING MARKET VALUE, BY COMPONENT, 2021-2030 (USD BILLION)
TABLE 72. MIDDLE EAST AND AFRICA 3D BIOPRINTING MARKET VALUE, BY APPLICATION, 2021-2030 (USD BILLION)
TABLE 73. MIDDLE EAST AND AFRICA 3D BIOPRINTING MARKET VALUE, BY END USERS, 2021-2030 (USD BILLION)
TABLE 74. SAUDI ARABIA 3D BIOPRINTING MARKET VALUE, BY COMPONENT, 2021-2030 (USD BILLION)
TABLE 75. SAUDI ARABIA 3D BIOPRINTING MARKET VALUE, BY APPLICATION, 2021-2030 (USD BILLION)
TABLE 76. SAUDI ARABIA 3D BIOPRINTING MARKET VALUE, BY END USERS, 2021-2030 (USD BILLION)
TABLE 77. UAE 3D BIOPRINTING MARKET VALUE, BY COMPONENT, 2021-2030 (USD BILLION)
TABLE 78. UAE 3D BIOPRINTING MARKET VALUE, BY APPLICATION, 2021-2030 (USD BILLION)
TABLE 79. UAE 3D BIOPRINTING MARKET VALUE, BY END USERS, 2021-2030 (USD BILLION)
TABLE 80. REST OF MIDDLE EAST AND AFRICA 3D BIOPRINTING MARKET VALUE, BY COMPONENT, 2021-2030 (USD BILLION)
TABLE 81. REST OF MIDDLE EAST AND AFRICA 3D BIOPRINTING MARKET VALUE, BY APPLICATION, 2021-2030 (USD BILLION)
TABLE 82. REST OF MIDDLE EAST AND AFRICA 3D BIOPRINTING MARKET VALUE, BY END USERS, 2021-2030 (USD BILLION)
TABLE 83. ENVISIONTEC, INC. : FINANCIALS
TABLE 84. ENVISIONTEC, INC. : PRODUCTS & SERVICES
TABLE 85. ENVISIONTEC, INC. : RECENT DEVELOPMENTS
TABLE 86. ORGANOVO HOLDINGS, INC.: FINANCIALS
TABLE 87. ORGANOVO HOLDINGS, INC.: PRODUCTS & SERVICES
TABLE 88. ORGANOVO HOLDINGS, INC.: RECENT DEVELOPMENTS
TABLE 89. INVENTIA LIFE SCIENCE PTY LTD: FINANCIALS
TABLE 90. INVENTIA LIFE SCIENCE PTY LTD: PRODUCTS & SERVICES
TABLE 91. INVENTIA LIFE SCIENCE PTY LTD: RECENT DEVELOPMENTS
TABLE 92. POIETIS: FINANCIALS
TABLE 93. POIETIS: PRODUCTS & SERVICES
TABLE 94. POIETIS: RECENT DEVELOPMENTS
TABLE 95. VIVAX BIO, LLC: FINANCIALS
TABLE 96. VIVAX BIO, LLC: PRODUCTS & SERVICES
TABLE 97. VIVAX BIO, LLC: RECENT DEVELOPMENTS
TABLE 98. ALLEVI: FINANCIALS
TABLE 99. ALLEVI: PRODUCTS & SERVICES
TABLE 100. ALLEVI: RECENT DEVELOPMENTS
TABLE 101. CYFUSE BIOMEDICAL K.K.: FINANCIALS
TABLE 102. CYFUSE BIOMEDICAL K.K.: PRODUCTS & SERVICES
TABLE 103. CYFUSE BIOMEDICAL K.K.: DEVELOPMENTS
TABLE 104. 3D BIOPRINTING SOLUTIONS: FINANCIALS
TABLE 105. 3D BIOPRINTING SOLUTIONS: PRODUCTS & SERVICES
TABLE 106. 3D BIOPRINTING SOLUTIONS: RECENT DEVELOPMENTS
TABLE 107. CELLINK GLOBAL: FINANCIALS
TABLE 108. CELLINK GLOBAL: PRODUCTS & SERVICES
TABLE 109. CELLINK GLOBAL: RECENT DEVELOPMENTS
TABLE 110. REGEMAT 3D S.L.: FINANCIALS
TABLE 111. REGEMAT 3D S.L.: PRODUCTS & SERVICES
TABLE 112. REGEMAT 3D S.L.: RECENT DEVELOPMENTS

ページTOPに戻る


プレスリリース

3Dバイオプリンティング市場：動向と予測-2022-2030年
"世界の3Dバイオプリンティング市場は2022年に20億米ドル規模であり、2023年から2030年にかけて年平均成長率（CAGR）20.4％で増加すると予測されている。増加の背景には、臓器提供者の不足と慢性呼吸器疾患を抱える高齢化がある。研究開発費の増加、技術革新、慢性疾患の有病率の増加はすべて、市場拡大を促進すると予測される要因である。3Dプリンティング・コミュニティは、COVID-19問題に反応し、流行に対処する病院のための重要な医療機器の製造をボランティアで支援している。

要点
- 本レポートは、3Dバイオプリンティング市場の最も重要な属性を示しており、これが市場を牽引し、機会を提供している。
- この調査レポートは、3Dバイオプリンティング市場の成長を市場のいくつかのセグメントに基づいて詳細に分析します。
- 3Dバイオプリンティング市場の過去と現在の動向予測を提示します。
- また、3Dバイオプリンティング市場の主要企業の主要戦略や能力などの競争分析も提示しています。

Infoholic Research社について
Infoholic Research社は、世界的な市場調査・コンサルティング機関です。新興のニッチ技術や市場のマーケットインテリジェンスを提供しています。厳格な方法論と質の高い指標を駆使した市場分析により、新興市場、新興技術、新興ビジネスモデルに関する情報と予測を提供します。業種や国別レポートに深くフォーカスすることで、お客様がビジネスチャンスを特定し、ビジネス戦略を策定するのに役立ちます。

連絡先
プレス・メディア連絡先
バスカール・ジョティ・ナス
インフォホリック・リサーチLLP
+91-80-22222833, +91-8867685927
bhaskar@infoholicresearch.com
電話番号080 411 411 05
電子メール：us.inquiry@infoholicresearch.com

　

ページTOPに戻る


　

Summary

Governments throughout the world are launching projects and sponsoring educational institutions, research centres, and research and technology organisations to further investigate and stimulate the development of 3D printing technology. The United States, the United Kingdom, and Canada have all launched government programmes aimed at fostering university-level 3D printing research, accelerating technological innovation, and establishing start-ups. The advent of novel uses for 3D printing has piqued the interest of businesses and governments worldwide. The UK National Strategy for Additive Manufacturing 2023-2030, for example, seeks to reach EUR 3,500 million in gross value added (GVA) per year by 2030, as well as 60,000 employment across industries. The plan represents a comprehensive set of proposals created by workgroups responsible for certain themes.



ページTOPに戻る


Table of Contents

1. Executive Summary
2. Industry Outlook
2.1. Industry Overview
2.2. Industry Trends
3. Market Snapshot
3.1. Market Definition
3.2. Market Outlook
3.2.1. Porter Five Forces
3.3. Related Markets
4. Market characteristics
4.1. Market Overview
4.2. Market Segmentation
4.3. Market Dynamics
4.3.1. Drivers
4.3.2. Restraints
4.3.3. Opportunities
4.4. DRO - Impact Analysis
5. Component: Market Size & Analysis
5.1. Overview
5.2. 3D Bioprinters
5.3. Bioinks
6. Application: Market Size & Analysis
6.1. Overview
6.2. Research applications
6.3. Clinical applications
7. End Users: Market Size & Analysis
7.1. Overview
7.2. Research Organizations and Academic Institutes,
7.3. Biopharmaceutical companies
7.4. Hospitals
8. Geography: Market Size & Analysis
8.1. Overview
8.2. North America (U.S., Mexico, Canada)
8.3. Europe (France, Germany, UK, Italy, Netherlands, Spain, Russia, Rest of Europe)
8.4. Asia Pacific (Japan, China, India, Australia, South East Asia, Rest of APAC)
8.5. Latin America (Brazil, Argentina)
8.6. Middle East & Africa (Saudi Arabia, UAE, South Africa, Rest of Middle East and Africa)
9. Competitive Landscape
9.1. Competitor Comparison Analysis
9.2. Market Developments
9.2.1. Mergers and Acquisitions, Legal, Awards, Partnerships
9.2.2. Product Launches and execution
10. Vendor Profiles
10.1. ENVISIONTEC, INC.
10.1.1. Overview
10.1.2. Financial Overview
10.1.3. Product Offerings
10.1.4. Developments
10.1.5. Business Strategy
10.2. ORGANOVO HOLDINGS, INC.
10.2.1. Overview
10.2.2. Financial Overview
10.2.3. Product Offerings
10.2.4. Developments
10.2.5. Business Strategy
10.3. INVENTIA LIFE SCIENCE PTY LTD
10.3.1. Overview
10.3.2. Financial Overview
10.3.3. Product Offerings
10.3.4. Developments
10.3.5. Business Strategy
10.4. POIETIS
10.4.1. Overview
10.4.2. Financial Overview
10.4.3. Product Offerings
10.4.4. Developments
10.4.5. Business Strategy
10.5. VIVAX BIO, LLC
10.5.1. Overview
10.5.2. Financial Overview
10.5.3. Product Offerings
10.5.4. Developments
10.5.5. Business Strategy
10.6. ALLEVI
10.6.1. Overview
10.6.2. Financial Overview
10.6.3. Product Offerings
10.6.4. Developments
10.6.5. Business Strategy
10.7. CYFUSE BIOMEDICAL K.K.
10.7.1. Overview
10.7.2. Financial Overview
10.7.3. Product Offerings
10.7.4. Developments
10.7.5. Business Strategy
10.8. 3D BIOPRINTING SOLUTIONS
10.8.1. Overview
10.8.2. Financial Overview
10.8.3. Product Offerings
10.8.4. Developments
10.8.5. Business Strategy
10.9. CELLINK GLOBAL
10.9.1. Overview
10.9.2. Financial Overview
10.9.3. Product Offerings
10.9.4. Developments
10.9.5. Business Strategy
10.10. REGEMAT 3D S.L.
10.10.1. Overview
10.10.2. Financial Overview
10.10.3. Product Offerings
10.10.4. Developments
10.10.5. Business Strategy

11. Analyst Opinion
12. Annexure

ページTOPに戻る



List of Tables/Graphs

TABLE 1. 3D BIOPRINTING MARKET VALUE, BY COMPONENT, 2021-2030 (USD BILLION)
TABLE 2. 3D BIOPRINTING MARKET VALUE FOR 3D BIOPRINTERS, BY GEOGRAPHY , 2021-2030 (USD BILLION)
TABLE 3. 3D BIOPRINTING MARKET VALUE FOR BIOINKS, BY GEOGRAPHY, 2021-2030 (USD BILLION)
TABLE 4. 3D BIOPRINTING MARKET VALUE, BY APPLICATION, 2021-2030 (USD BILLION)
TABLE 5. 3D BIOPRINTING MARKET VALUE FOR RESEARCH APPLICATIONS, 2021-2030 (USD BILLION)
TABLE 6. 3D BIOPRINTING MARKET VALUE FOR CLINICAL APPLICATIONS, BY GEOGRAPHY, 2021-2030 (USD BILLION)
TABLE 7. 3D BIOPRINTING MARKET VALUE, BY END USERS, 2021-2030 (USD BILLION)
TABLE 8. 3D BIOPRINTING MARKET VALUE FOR RESEARCH ORGANIZATIONS AND ACADEMIC INSTITUTES, BY GEOGRAPHY, 2021-2030 (USD BILLION)
TABLE 9. 3D BIOPRINTING MARKET VALUE FOR BIOPHARMACEUTICAL COMPANIES, BY GEOGRAPHY, 2021-2030 (USD BILLION)
TABLE 10. 3D BIOPRINTING MARKET VALUE FOR HOSPITALS, BY GEOGRAPHY, 2021-2030 (USD BILLION)
TABLE 11. NORTH AMERICA 3D BIOPRINTING MARKET VALUE, BY COUNTRY, 2021-2030 (USD BILLION)
TABLE 12. NORTH AMERICA 3D BIOPRINTING MARKET VALUE, BY COMPONENT, 2021-2030 (USD BILLION)
TABLE 13. NORTH AMERICA 3D BIOPRINTING MARKET VALUE, BY APPLICATION, 2021-2030 (USD BILLION)
TABLE 14. NORTH AMERICA 3D BIOPRINTING MARKET VALUE, BY END USERS, 2021-2030 (USD BILLION)
TABLE 15. U.S 3D BIOPRINTING MARKET VALUE, BY COMPONENT, 2021-2030 (USD BILLION)
TABLE 16. U.S 3D BIOPRINTING MARKET VALUE, BY APPLICATION, 2021-2030 (USD BILLION)
TABLE 17. U.S 3D BIOPRINTING MARKET VALUE, BY END USERS, 2021-2030 (USD BILLION)
TABLE 18. CANADA 3D BIOPRINTING MARKET VALUE, BY COMPONENT, 2021-2030 (USD BILLION)
TABLE 19. CANADA 3D BIOPRINTING MARKET VALUE, BY APPLICATION, 2021-2030 (USD BILLION)
TABLE 20. CANADA 3D BIOPRINTING MARKET VALUE, BY END USERS, 2021-2030 (USD BILLION)
TABLE 21. MEXICO 3D BIOPRINTING MARKET VALUE, BY COMPONENT, 2021-2030 (USD BILLION)
TABLE 22. MEXICO 3D BIOPRINTING MARKET VALUE, BY APPLICATION, 2021-2030 (USD BILLION)
TABLE 23. MEXICO 3D BIOPRINTING MARKET VALUE, BY END USERS, 2021-2030 (USD BILLION)
TABLE 24. EUROPE 3D BIOPRINTING MARKET VALUE, BY COUNTRY, 2021-2030 (USD BILLION)
TABLE 25. EUROPE 3D BIOPRINTING MARKET VALUE, BY COMPONENT, 2021-2030 (USD BILLION)
TABLE 26. EUROPE 3D BIOPRINTING MARKET VALUE, BY APPLICATION, 2021-2030 (USD BILLION)
TABLE 27. EUROPE 3D BIOPRINTING MARKET VALUE, BY END USERS, 2021-2030 (USD BILLION)
TABLE 28. GERMANY 3D BIOPRINTING MARKET VALUE, BY COMPONENT, 2021-2030 (USD BILLION)
TABLE 29. GERMANY 3D BIOPRINTING MARKET VALUE, BY APPLICATION, 2021-2030 (USD BILLION)
TABLE 30. GERMANY 3D BIOPRINTING MARKET VALUE, BY END USERS, 2021-2030 (USD BILLION)
TABLE 31. U.K 3D BIOPRINTING MARKET VALUE, BY COMPONENT, 2021-2030 (USD BILLION)
TABLE 32. U.K 3D BIOPRINTING MARKET VALUE, BY APPLICATION, 2021-2030 (USD BILLION)
TABLE 33. U.K 3D BIOPRINTING MARKET VALUE, BY END USERS, 2021-2030 (USD BILLION)
TABLE 34. FRANCE 3D BIOPRINTING MARKET VALUE, BY COMPONENT, 2021-2030 (USD BILLION)
TABLE 35. FRANCE 3D BIOPRINTING MARKET VALUE, BY APPLICATION, 2021-2030 (USD BILLION)
TABLE 36. FRANCE 3D BIOPRINTING MARKET VALUE, BY END USERS, 2021-2030 (USD BILLION)
TABLE 37. ITALY 3D BIOPRINTING MARKET VALUE, BY COMPONENT, 2021-2030 (USD BILLION)
TABLE 38. ITALY 3D BIOPRINTING MARKET VALUE, BY APPLICATION, 2021-2030 (USD BILLION)
TABLE 39. ITALY 3D BIOPRINTING MARKET VALUE, BY END USERS, 2021-2030 (USD BILLION)
TABLE 40. SPAIN 3D BIOPRINTING MARKET VALUE, BY COMPONENT, 2021-2030 (USD BILLION)
TABLE 41. SPAIN 3D BIOPRINTING MARKET VALUE, BY APPLICATION, 2021-2030 (USD BILLION)
TABLE 42. SPAIN 3D BIOPRINTING MARKET VALUE, BY END USERS, 2021-2030 (USD BILLION)
TABLE 43. ROE 3D BIOPRINTING MARKET VALUE, BY COMPONENT, 2021-2030 (USD BILLION)
TABLE 44. ROE 3D BIOPRINTING MARKET VALUE, BY APPLICATION, 2021-2030 (USD BILLION)
TABLE 45. ROE 3D BIOPRINTING MARKET VALUE, BY END USERS, 2021-2030 (USD BILLION)
TABLE 46. ASIA PACIFIC 3D BIOPRINTING MARKET VALUE, BY COUNTRY, 2021-2030 (USD BILLION)
TABLE 47. ASIA PACIFIC 3D BIOPRINTING MARKET VALUE, BY COMPONENT, 2021-2030 (USD BILLION)
TABLE 48. ASIA PACIFIC 3D BIOPRINTING MARKET VALUE, BY APPLICATION, 2021-2030 (USD BILLION)
TABLE 49. ASIA PACIFIC 3D BIOPRINTING MARKET VALUE, BY END USERS, 2021-2030 (USD BILLION)
TABLE 50. CHINA 3D BIOPRINTING MARKET VALUE, BY COMPONENT, 2021-2030 (USD BILLION)
TABLE 51. CHINA 3D BIOPRINTING MARKET VALUE, BY APPLICATION, 2021-2030 (USD BILLION)
TABLE 52. CHINA 3D BIOPRINTING MARKET VALUE, BY END USERS, 2021-2030 (USD BILLION)
TABLE 53. INDIA 3D BIOPRINTING MARKET VALUE, BY COMPONENT, 2021-2030 (USD BILLION)
TABLE 54. INDIA 3D BIOPRINTING MARKET VALUE, BY APPLICATION, 2021-2030 (USD BILLION)
TABLE 55. INDIA 3D BIOPRINTING MARKET VALUE, BY END USERS, 2021-2030 (USD BILLION)
TABLE 56. JAPAN 3D BIOPRINTING MARKET VALUE, BY COMPONENT, 2021-2030 (USD BILLION)
TABLE 57. JAPAN 3D BIOPRINTING MARKET VALUE, BY APPLICATION, 2021-2030 (USD BILLION)
TABLE 58. JAPAN 3D BIOPRINTING MARKET VALUE, BY END USERS, 2021-2030 (USD BILLION)
TABLE 59. REST OF APAC 3D BIOPRINTING MARKET VALUE, BY COMPONENT, 2021-2030 (USD BILLION)
TABLE 60. REST OF APAC 3D BIOPRINTING MARKET VALUE, BY APPLICATION, 2021-2030 (USD BILLION)
TABLE 61. REST OF APAC 3D BIOPRINTING MARKET VALUE, BY END USERS, 2021-2030 (USD BILLION)
TABLE 62. LATIN AMERICA 3D BIOPRINTING MARKET VALUE, BY COMPONENT, 2021-2030 (USD BILLION)
TABLE 63. LATIN AMERICA 3D BIOPRINTING MARKET VALUE, BY APPLICATION, 2021-2030 (USD BILLION)
TABLE 64. LATIN AMERICA 3D BIOPRINTING MARKET VALUE, BY END USERS, 2021-2030 (USD BILLION)
TABLE 65. BRAZIL 3D BIOPRINTING MARKET VALUE, BY COMPONENT, 2021-2030 (USD BILLION)
TABLE 66. BRAZIL 3D BIOPRINTING MARKET VALUE, BY APPLICATION, 2021-2030 (USD BILLION)
TABLE 67. BRAZIL 3D BIOPRINTING MARKET VALUE, BY END USERS, 2021-2030 (USD BILLION)
TABLE 68. ARGENTINA 3D BIOPRINTING MARKET VALUE, BY COMPONENT, 2021-2030 (USD BILLION)
TABLE 69. ARGENTINA 3D BIOPRINTING MARKET VALUE, BY APPLICATION, 2021-2030 (USD BILLION)
TABLE 70. ARGENTINA 3D BIOPRINTING MARKET VALUE, BY END USERS, 2021-2030 (USD BILLION)
TABLE 71. MIDDLE EAST AND AFRICA 3D BIOPRINTING MARKET VALUE, BY COMPONENT, 2021-2030 (USD BILLION)
TABLE 72. MIDDLE EAST AND AFRICA 3D BIOPRINTING MARKET VALUE, BY APPLICATION, 2021-2030 (USD BILLION)
TABLE 73. MIDDLE EAST AND AFRICA 3D BIOPRINTING MARKET VALUE, BY END USERS, 2021-2030 (USD BILLION)
TABLE 74. SAUDI ARABIA 3D BIOPRINTING MARKET VALUE, BY COMPONENT, 2021-2030 (USD BILLION)
TABLE 75. SAUDI ARABIA 3D BIOPRINTING MARKET VALUE, BY APPLICATION, 2021-2030 (USD BILLION)
TABLE 76. SAUDI ARABIA 3D BIOPRINTING MARKET VALUE, BY END USERS, 2021-2030 (USD BILLION)
TABLE 77. UAE 3D BIOPRINTING MARKET VALUE, BY COMPONENT, 2021-2030 (USD BILLION)
TABLE 78. UAE 3D BIOPRINTING MARKET VALUE, BY APPLICATION, 2021-2030 (USD BILLION)
TABLE 79. UAE 3D BIOPRINTING MARKET VALUE, BY END USERS, 2021-2030 (USD BILLION)
TABLE 80. REST OF MIDDLE EAST AND AFRICA 3D BIOPRINTING MARKET VALUE, BY COMPONENT, 2021-2030 (USD BILLION)
TABLE 81. REST OF MIDDLE EAST AND AFRICA 3D BIOPRINTING MARKET VALUE, BY APPLICATION, 2021-2030 (USD BILLION)
TABLE 82. REST OF MIDDLE EAST AND AFRICA 3D BIOPRINTING MARKET VALUE, BY END USERS, 2021-2030 (USD BILLION)
TABLE 83. ENVISIONTEC, INC. : FINANCIALS
TABLE 84. ENVISIONTEC, INC. : PRODUCTS & SERVICES
TABLE 85. ENVISIONTEC, INC. : RECENT DEVELOPMENTS
TABLE 86. ORGANOVO HOLDINGS, INC.: FINANCIALS
TABLE 87. ORGANOVO HOLDINGS, INC.: PRODUCTS & SERVICES
TABLE 88. ORGANOVO HOLDINGS, INC.: RECENT DEVELOPMENTS
TABLE 89. INVENTIA LIFE SCIENCE PTY LTD: FINANCIALS
TABLE 90. INVENTIA LIFE SCIENCE PTY LTD: PRODUCTS & SERVICES
TABLE 91. INVENTIA LIFE SCIENCE PTY LTD: RECENT DEVELOPMENTS
TABLE 92. POIETIS: FINANCIALS
TABLE 93. POIETIS: PRODUCTS & SERVICES
TABLE 94. POIETIS: RECENT DEVELOPMENTS
TABLE 95. VIVAX BIO, LLC: FINANCIALS
TABLE 96. VIVAX BIO, LLC: PRODUCTS & SERVICES
TABLE 97. VIVAX BIO, LLC: RECENT DEVELOPMENTS
TABLE 98. ALLEVI: FINANCIALS
TABLE 99. ALLEVI: PRODUCTS & SERVICES
TABLE 100. ALLEVI: RECENT DEVELOPMENTS
TABLE 101. CYFUSE BIOMEDICAL K.K.: FINANCIALS
TABLE 102. CYFUSE BIOMEDICAL K.K.: PRODUCTS & SERVICES
TABLE 103. CYFUSE BIOMEDICAL K.K.: DEVELOPMENTS
TABLE 104. 3D BIOPRINTING SOLUTIONS: FINANCIALS
TABLE 105. 3D BIOPRINTING SOLUTIONS: PRODUCTS & SERVICES
TABLE 106. 3D BIOPRINTING SOLUTIONS: RECENT DEVELOPMENTS
TABLE 107. CELLINK GLOBAL: FINANCIALS
TABLE 108. CELLINK GLOBAL: PRODUCTS & SERVICES
TABLE 109. CELLINK GLOBAL: RECENT DEVELOPMENTS
TABLE 110. REGEMAT 3D S.L.: FINANCIALS
TABLE 111. REGEMAT 3D S.L.: PRODUCTS & SERVICES
TABLE 112. REGEMAT 3D S.L.: RECENT DEVELOPMENTS

ページTOPに戻る


Press Release

3D Bioprinting Market : Trends & Forecast – 2022-2030
“The worldwide 3D bioprinting market was worth USD 2.0 billion in 2022, and it is predicted to increase at a compound annual growth rate (CAGR) of 20.4% between 2023 and 2030. The increase is attributable to a scarcity of organ donors and an ageing population with chronic respiratory disorders. Rising R&D expenditure, technological innovation, and an increase in the prevalence of chronic illnesses are all factors that are projected to drive market expansion. The 3D printing community has reacted to the COVID-19 problem by volunteering to assist in the manufacturing of critical medical equipment for hospitals dealing with the epidemic.

Essential Takeaways
• This report illustrates the most vital attributes of the 3D Bioprinting Market, which are driving and providing opportunities.
• This research gives an in-depth analysis of the 3D Bioprinting Market growth on the basis of several segments in the market.
• This report presents the predictions of the past and present trends of the 3D Bioprinting Market.
• This study also presents the competitive analysis, such as key strategies and capabilities of major players of the 3D Bioprinting Market.

About Infoholic Research
Infoholic Research is a global market research and consulting organization. We provide market intelligence in emerging, niche technologies and markets. Our market analysis powered by rigorous methodology and quality metrics provide information and forecasts across emerging markets, emerging technologies and emerging business models. Our deep focus on industry verticals and country reports help our clients to identify opportunities and develop business strategies.

Contact:
Press and Media Contacts
Bhaskar Jyothi Nath
Infoholic Research LLP
+91-80-22222833, +91-8867685927
bhaskar@infoholicresearch.com
Phone: 080 411 411 05
Email: us.inquiry@infoholicresearch.com

　

ページTOPに戻る

ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。

webからのご注文・お問合せはこちらのフォームから承ります

本レポートと同分野（医療）の最新刊レポート

IHR Insights社の医療分野での最新刊レポート

本レポートと同じKEY WORD（hydrogel）の最新刊レポート


よくあるご質問


IHR Insights社はどのような調査会社ですか?


IHR InsightsはICT、化学品、ヘルスケア、半導体など、世界の幅広い分野を対象に調査し、専門的な知識を基に市場調査報告書を出版しています。 主な調査分野 ◇ICT ◇化学品、材料、... もっと見る


調査レポートの納品までの日数はどの程度ですか?


在庫のあるものは速納となりますが、平均的には 3-４日と見て下さい。
但し、一部の調査レポートでは、発注を受けた段階で内容更新をして納品をする場合もあります。
発注をする前のお問合せをお願いします。


注文の手続きはどのようになっていますか?


1)お客様からの御問い合わせをいただきます。
2)見積書やサンプルの提示をいたします。
3)お客様指定、もしくは弊社の発注書をメール添付にて発送してください。
4)データリソース社からレポート発行元の調査会社へ納品手配します。
5) 調査会社からお客様へ納品されます。最近は、pdfにてのメール納品が大半です。


お支払方法の方法はどのようになっていますか?


納品と同時にデータリソース社よりお客様へ請求書（必要に応じて納品書も）を発送いたします。
お客様よりデータリソース社へ（通常は円払い）の御振り込みをお願いします。
請求書は、納品日の日付で発行しますので、翌月最終営業日までの当社指定口座への振込みをお願いします。振込み手数料は御社負担にてお願いします。
お客様の御支払い条件が60日以上の場合は御相談ください。
尚、初めてのお取引先や個人の場合、前払いをお願いすることもあります。ご了承のほど、お願いします。


データリソース社はどのような会社ですか?


当社は、世界各国の主要調査会社・レポート出版社と提携し、世界各国の市場調査レポートや技術動向レポートなどを日本国内の企業・公官庁及び教育研究機関に提供しております。
世界各国の「市場・技術・法規制などの」実情を調査・収集される時には、データリソース社にご相談ください。
お客様の御要望にあったデータや情報を抽出する為のレポート紹介や調査のアドバイスも致します。



詳細検索

このレポートへのお問合せ

お問合せはこちらから

03-3582-2531

電話お問合せもお気軽に

 

2024/11/21　10:26

156.13 円

165.08 円

200.38 円

ページTOPに戻る

株式会社 データリソース　Data Resources, Inc.
東京都港区赤坂1-14-5　アークヒルズエグゼクティブタワー N313

電話：03-3582-2531
FAX：03-3582-2861
Eメール：office@dri.co.jp

FAQ サイトマップ プライバシーポリシー お問合せ

関連会社:
株式会社ユーディーアール

COPYRIGHT(C) 2011-2023　DATA RESOURCES, Inc. ALL RIGHTS RESERVED.